PIKE THERAPEUTICS

Our platform reduces the area under the curve (AUC) and maximum plasma concentration (Cmax) and targets a continuous therapeutic effect while avoiding periods of subtherapeutic dosing. We are able to offer significantly less drug exposure compared to oral administration which increases tolerability, decreases toxicity, and significantly reduces adverse events and negative side effects... To address patient's needs, Pike is developing proprietary transdermal CBD technology that can provide continuous treatment delivery over a 7 day period. This would be the first Parkinson's specific therapy targeted to treat multiple non-motor symptoms and motor symptoms... Welcome to the Pike Therapeutics website. Find out about how we're pioneering a new approach in transdermal technology.

Also known as: Pike Therapeutics Inc.

Primary location: Vancouver